b'MOQC Measures, continued curative intent; bone-modifying agentWhataboutVBR?Each practices region will be abstracted for breast canceras a whole must meet 3 out of 4 VBR Med Onc Measures: patients who have metastatic diseasemeasure targets to qualify for the 3% CQI Congratulations! Our MOQCand for multiple myeloma patients; and aincentive. In addition to meeting the VBR practices have done so well reportingcomplete family history will be assessedtargets, one physician from each practice documentation of signed consent forfor any patient who has an invasive cancer.must attend both regional meetings and chemotherapy, discussing infertility risksA complete family history means thatone biannual meeting. prior to starting chemotherapy to patientsfor the first and second generation of aMOQCs webinars have a wealth of of reproductive age, colonoscopy beforepatients family, the type of cancer and theinformation regarding measure changes or within 6 months of curative colorectalage of diagnosis is noted in the patientsfor this round and are available for resection or completion of primaryrecord or is indicated as not availableviewing on our website, moqc.org. adjuvant chemo, addressing dyspnea,or unknown. QOPI collaborated withGynOnc Measures: and assessing/addressing paintheseMOQC to create 3 MOQC test measures. measures have been retired. Depending on how the measure performsMOQCs GynOnc measures have not SomethingNew!Three measures werein MOQC practices (Do we see variation?undergone any revisions since first Is the measure feasible to collect? Is therepublished.reconfigured to address current practice.an opportunity to improve performance?), Granulocyte colony-stimulating factorthey have the potential to be incorporated (GCSF) will be abstracted for any patientinto the QOPI database. who is receiving chemotherapy for non-MOQC MEMBERSMed Onc Locations Gyn Onc LocationsThe member maps are interactive on the moqc.org website.5'